4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034935
Chief Financial Officer bought 125,000 shares at $0.26 ($32,338)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hunt Jonathan Robert Chief Financial Officer | 2023-12-18 | Purchase | +125,000 | $0.26 | $32,338 | 316,710 | D: show line 1 in the form |
| Open-market purchases · 125,000 sh · avg $0.26 · $32,338 | |||||||
Loading xslF345X05/rdgdoc.xml…